AstraZeneca files for US FDA approval of HUTCHMED lung cancer drug combination
- Posted on September 29, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
AstraZeneca files for US FDA approval of HUTCHMED lung cancer drug combination
Sept 29 (Reuters) - HUTCHMED (China) said on Tuesday that Anglo-Swedish drugmaker AstraZeneca had applied to the US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO combination to treat patients with advanced lung cancer. ORPATHYS is being jointly developed by AstraZeneca and HUTCHMED and is commercialised by AstraZeneca. Here are some details: • The company said the
